SEC Form 4 · accession 0001209191-17-058099
GYRE THERAPEUTICS, INC. · GYRE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrea Hunt
Director
Period of report
Oct 25, 2017
Accepted (ET)
Oct 26, 2017 · 9:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001124105
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.72 | Oct 25, 2017 | A | 10,000 | A | — | Oct 25, 2027 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1The Option shall vest monthly over a period of three years commencing October 25, 2017.